This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Service
see PharmacoEconomics & Outcomes News 734 p34; 809182252
Reference
Hawkes N. NICE approval of new hepatitis drug could result in 700m bill for NHS. BMJ 2015: h5554, No. 351, 21 Oct 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h5554
Rights and permissions
About this article
Cite this article
NICE's approval of hepatitis drugs may create cost dilemma. PharmacoEcon Outcomes News 740, 7 (2015). https://doi.org/10.1007/s40274-015-2562-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2562-3